PetDx to collab for dog cancer testing
by Katie Pfaff
Pet health molecular diagnostics company, PetDx, and the veterinary teleconsultation platform, Fidu, will collaborate to link internal medicine veterinarians and oncology veterinarians when the dog is being tested using the OncoK9 liquid biopsy. The collaboration increases access to testing for patients which may not have ready access to specialists.
While specialist care is necessary for oncology, access to specialists may be difficult in some areas or cause the pet and owner to have to wait for an appointment, thereby potentially delaying treatment. By using the collaborative program, patients will have treatment backed by access to the information available with Fidu’s platform which is bolstered by experts with veterinary oncology and veterinary internal medicine experience.
“We're committed to empowering veterinarians to provide superior care to canine patients by helping them work up complicated clinical cases or discuss potential care options," said Dr. Katie Lytle, director of customer support and success management at PetDx. "This collaboration ensures that veterinarians offering OncoK9 to their clients have access to specialists through our partnership with Fidu. We are delighted to be able to offer their support and expertise to our customers."
Through the dual effort, veterinarians suspicious of cancer, prescribe OncoK9 multi-cancer early detection testing. The veterinarian who prescribed the test is then eligible to access the PetDx experts who are familiar with the type of case presented.
"As a general practitioner, I appreciate OncoK9 as a novel tool that can help veterinarians diagnose cancer earlier in canine patients. Knowing that there is a specialist to provide some guidance once the results are in gives us the best set of information and options to relay to the pet owners, allowing everyone to move forward with their pet's diagnosis and treatment sooner," said Dr. Caitlin DeWilde, chief operations officer at Fidu.
Comments
Tag
Related Articles
More news
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment